Monitoring and Cognitive Appraisal: The Etiology of Psychological Disorders and The Divergence Between Behavioural and Self-reported Data
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- AX-CPT (AX-Continuous Performance Test)
研究概览
简要总结
The study investigates the etiology of psychogical disorders from a neuropsychological perspective based on monitoring and cognitive appraisal.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •geriatric patient of the St. Franziskus-Hospital, Germany.
排除标准
- •severe dementia
- •psychotic disorders
结局指标
主要结局
AX-CPT (AX-Continuous Performance Test)
时间窗: from beginning (day 2) of the hospitalization to the end (day 14) of the biweekly pre-rehabilitative treatment.
The AX-CPT assesses cognitive control through error rates and reaction times. Range: Error rate: 0-100%; Reaction time: measured in milliseconds Interpretation: Lower error rates and faster reaction times indicate better cognitive control performance.
CCFQ (Cognitive Control and Flexibility Questionnaire)
时间窗: Day 1 (pretest) and Day 14 (posttest)
The CCFQ measures self-reported cognitive flexibility and control. Scale title: Cognitive Control and Flexibility Questionnaire Range: 1-7 per item Interpretation: Higher scores indicate greater cognitive flexibility and control.
BSI-18 (Brief Symptom Inventory - 18)
时间窗: Day 1 (pretest) and Day 14 (posttest)
T he BSI-18 assesses psychological symptom severity in terms of depression, anxiety, and somatization.T Scale title: Brief Symptom Inventory - 18 Range: 0-4 per item Interpretation: Higher scores indicate greater symptom severity.
MHC-SF (Mental Health Continuum - Short Form)
时间窗: Day 1 (pretest) and Day 14 (posttest)
Measures emotional, psychological, and social well-being. Range: 1-6 per item Interpretation: Higher scores indicate better mental health.
次要结局
- General Self-Efficacy assessed via General Self-Efficacy Scale (SWE)(Day 1 (pretest) and Day 14 (posttest))
- Treatment Beliefs assessed via Palermo Questionnaire(Day 1 (pretest) and Day 14 (posttest))
研究者
Leon Alker
Chief Clinical Neuropsychologist (Winterberg, Germany)
St. Franziskus Hospital